TITLE

High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

AUTHOR(S)
Berardi, S.; Lodato, F.; Gramenzi, A.; D'Errica, A.; Lenzi, M.; Bontadini, A.; Morelli, M. C.; Tamè, M. R.; Piscaglia, F.; Biselli, M.; Sama, C.; Mazzella, G.; Pinna, A. D.; Grazi, G.; Bernardi, M.; Andreone, P.
PUB. DATE
February 2007
SOURCE
Gut;Feb2007, Vol. 56 Issue 2, p237
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Interferon may trigger autoimmune disorders, including autoimmune hepatitis, in immunocompetent patients. To date, no such disorders have been described in liver transplanted patients. Methods: 9 of 44 liver transplanted patients who had been receiving pegylated-interferon alpha-2b and ribavirin for at least 6 months for hepatitis C virus (HCV) recurrence, developed graft dysfunction despite on- treatment HCV-RNA clearance in all but one case. Laboratory, microbiological, imaging and histological evaluations were performed to identify the origin of graft dysfunction. The International Autoimmune Hepatitis scoring system was also applied. Results: In all cases infections, anastomoses complications and rejection were excluded, whereas the autoimmune hepatitis score suggested a "probable autoimmune hepatitis" (score from 10 to 14). Three patients developed other definite autoimmune disorders (overlap anti-mitochondrial antibodies (AMA)- positive cholangitis, autoimmune thyroiditis and systemic lupus erythematosus, respectively). In all cases, pre- existing autoimmune hepatitis was excluded. Anti-lymphocyte antibodies in immunosuppressive induction treatment correlated with the development of the disorder, whereas the use of granulocyte colony-stimulating factor to treat interferon-induced neutropenia showed a protective role. Withdrawal of antiviral treatment and treatment with prednisone resulted in different outcomes (five remissions and four graft failures with two deaths). Conclusions: De novo autoimmune hepatitis should be considered in differential diagnosis along with rejection in liver transplanted patients developing graft dysfunction while on treatment with interferon.
ACCESSION #
24040267

 

Related Articles

  • Tacrolimus: A Potential New Treatment for Autoimmune Chronic Active Hepatitis: Results of an Open-Label Preliminary Trial. Van Thiel, David H.; Wright, Harlan; Carroll, Patricia; Abu-Elmagd, Kareem; Rodriguez-Rilo, Horacio; McMichael, John; Irish, William; Starzl, Thomas E. // American Journal of Gastroenterology;May1995, Vol. 90 Issue 5, p771 

    Autoimmune chronic active hepatitis (CAH-A) is a chronic liver disease of unknown etiology that is believed to have an autoimmune pathogenesis. The disease is slowly progressive until hepatic failure and portal hypertension develop and either death or liver transplantation occur. Currently, the...

  • Autoimmune paediatric liver disease. Mieli-Vergani, Giorgina; Vergani, Diego // World Journal of Gastroenterology;6/7/2008, Vol. 14 Issue 21, p3360 

    Liver disorders with a likely autoimmune pathogenesis in childhood include autoimmune hepatitis (AIH), autoimmune sclerosing cholangitis (ASC), and de novo AIH after liver transplantation. AIH is divided into two subtypes according to seropositivity for smooth muscle and/or antinuclear antibody...

  • Prevalence of autoimmune liver disease in Alaska natives. Hurlburt, Kathy J.; McMahon, Brian J.; Deubner, Heike; Hsu-Trawinski, Barbara; Williams, James L.; Kowdley, Kris V. // American Journal of Gastroenterology;Sep2002, Vol. 97 Issue 9, p2402 

    OBJECTIVE:There is limited information on the prevalence of autoimmune liver disease in nonwhite populations. We conducted a population-based study on the prevalence of autoimmune liver diseases in Alaska natives.METHODS:Clinical records from 1984 to July, 2000 were reviewed to identify Alaska...

  • Reporte de dos casos de síndrome de sobreposición entre hepatitis autoinmune y cirrosis biliar primaria. Herrera, Yeinis Paola Espinoza; Gutiérrez, Juan Carlos Restrepo; Duque, Sergio Hoyos; Arango, Gonzalo Correa // Revista Colombiana de Gastroenterología;Oct2010, Vol. 25 Issue 4, p399 

    We present the cases of two female patients with clinical, serological, immunological, and histological characteristics which mixed symptoms of autoimmune hepatitis and primary biliary cirrhosis. Orthotopic liver transplantation was chosen as the best therapeutic alternative for both patients...

  • POSTHEPATITIC CIRRHOSIS. Spain, David M. // American Journal of Gastroenterology;Oct1955, Vol. 24 Issue 4, p428 

    Presents information on posthepatitic cirrhosis. Incidence of posthepatitic cirrhosis; Forms of posthepatitic cirrhosis; Relationship of posthepatitic cirrhosis with other forms.

  • Successful Pregnancy in Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome: A Case Report. Mitra, Subarna; Nayak, Prasanta Kumar; Padma, Alaganandam; Kurian, George // Gastroenterology Research;2012, Vol. 5 Issue 5, p208 

    Medical literature on pregnancy outcomes in hepatic overlap syndromes is limited. Autoimmune liver diseases are associated with sub-fertility and pregnancy is usually dissuaded in presence of portal hypertension and cirrhosis due to guarded prognosis for the pregnancy as well as the liver...

  • Corticosteroid-Responsive Cryptogenic Chronic Hepatitis: Evidence for Seronegative Autoimmune Hepatitis. Daniel Gassert; Heriberto Garcia; Katherine Tanaka; John Reinus // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2433 

    Abstract  Cryptogenic chronic hepatitis (CCH) is diagnosed in patients with persistently elevated aminotransferase levels of unknown etiology. The workup of CCH patients must include a liver biopsy in order to exclude the largely unrecognized diagnosis of seronegative autoimmune...

  • Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis. De Biasio, M. B.; Periolo, N.; Avagnina, A.; Garcia De Dávila, M. I.; Ciocca, M.; Goñi, J.; De Matteo, E.; Galoppo, C.; Cañero-Velasco, M. C.; Fainboim, H.; Muñoz, A. E.; Fainboim, L.; Cherñavsky, A. C. // Journal of Clinical Pathology;Apr2006, Vol. 59 Issue 4, p417 

    Objective: To investigate infiltrating cells in the liver of children with type 1 autoimmune hepatitis (AH-1). Methods: liver biopsies from 24 untreated AH-1 patients (14 children, 10 adults), five patients with hepatitis C virus related chronic hepatitis (HCV), and 10 control liver specimens...

  • Autoimmune Hepatitis: A Brief Review With an Emphasis on Autoimmune Testing. Michael Nimmo // Laboratory Medicine;Apr2007, Vol. 38 Issue 4, p248 

    Hepatitis is the general term for inflammation of the liver. The most common causes of hepatitis are the hepatotropic viruses (hepatisis A, B, C, etc.) and alcohol abuse. Autoimmune hepatitis (AIH) appears to result from an interaction between genetic and environmental factors. The laboratory...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics